Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25
While they are not reviewed or approved by the FDA for safety or effectiveness, they are made in accordance with strict regulatory guidelines
That gap widens over time, from roughly 4-5 percentage points at 24 weeks to over 6 percentage points by 68-72 weeks
If labs are needed, your provider will guide you through the process during your consultation
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound) in adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
US$ 29.82
US$ 21.01
US$ 26.24
US$ 22.73
US$ 27.96
US$ 25.57
